Current Topics in Medicinal Chemistry

Graphical Abstracts:
pp. i-iii(3)

Dedication to Dr. Allen B. Reitz, Editor-in-Chief, CTMC
pp. 1071-1071(1)
Authors: Honan, Matthew; Alam, Mahmood; Irshad, Ambreen

Editorial (Thematic Issue: Current and Emerging Drug Targets for Human Immunodeficiency Virus)
pp. 1072-1073(2)
Authors: A. Waheed, Abdul; Tachedjian, Gilda

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41
pp. 1074-1090(17)
Authors: Lu, Lu; Yu, Fei; Cai, Lifeng; K. Debnath, Asim; Jiang, Shibo

Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes
pp. 1091-1106(16)
Authors: Roche, Michael; Borm, Katharina; K. Flynn, Jacqueline; R. Lewin, Sharon; J. Churchill, Melissa; R. Gorry, Paul

Contemporary HIV Vaccines: Tissue Resident T-Cells and Strategies to Prevent Mucosal Infection
pp. 1107-1117(11)
Authors: Tan, Hyon-Xhi; J. Kent, Stephen; De Rose, Robert

Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV
pp. 1118-1134(17)
Authors: W. Buckheit, Karen; Furlan-Freguia, Christian; S. Ham, Anthony; W. Buckheit, Robert

Fragment Based Strategies for Discovery of Novel HIV-1 Reverse Transcriptase and Integrase Inhibitors
pp. 1135-1153(19)
Authors: CatherineLatham; La, Jennifer; N. Tinetti, Ricky; K. Chalmers, David; Tachedjian, Gilda

HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors
pp. 1154-1166(13)
Author: Spearman, Paul

Targeting Virus-host Interactions of HIV Replication
pp. 1167-1190(24)
Authors: Weydert, Caroline; De Rijck, Jan; Christ, Frauke; Debyser, Zeger

Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells
pp. 1191-1197(7)
Author: Sluis-Cremer, Nicolas